CClinicalTrials.gg
Not yet recruitingNCT07765680YOGENDOCHIRUpdated Sep 21, 2026

Perioperative Yoga Therapy and Endometriosis Surgery

An interventional study of Standard surgical management for endometriosis and Structured perioperative yogatherapy programme plus standard surgical management in Endometriosis, Chronic Pain and Impairment of Quality of Life, sponsored by University Hospital, Lille. Not yet recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by University Hospital, Lille · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
188
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

YOGENDOCHIR is a multicentre, prospective, randomised, controlled, parallel-group study involving 188 adult women scheduled to undergo surgery for endometriosis.

The study compares standard surgical management alone with the same management combined with a structured perioperative yoga therapy programme comprising 32 guided sessions (16 before and 16 after surgery), supplemented by a secure digital platform supporting independent practice and adherence monitoring.

The primary objective is to assess the effect of yoga therapy on endometriosis-related pain, as measured by the pain subscale of the Endometriosis Health Profile-30 (EHP-30). Participants are assessed before surgery and at 3, 6, and 12 months after the procedure.

Secondary outcomes include quality of life, pain characteristics, fatigue, sleep, anxiety and depressive symptoms, sexual health, kinesiophobia, activities of daily living, medication use, healthcare utilisation, absenteeism, adherence, satisfaction, and the participants' ability to use the platform independently.

02

Conditions studied

  • Endometriosis
  • Chronic Pain
  • Impairment of Quality of Life

Keywords

  • Endometriosis
  • chronic pain
  • yogatherapy
  • surgery
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Eligibility criteria

  • Adult woman (18 years or older) covered by a social health insurance scheme.
  • Surgery for endometriosis is indicated.
  • No assisted reproductive technology (ART) protocol planned within 6 months after surgery.
  • No chronic pain attributable to another disease or condition.
  • No yoga practice outside the study during participation.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
188 participants (estimated)

Study arms

  • Experimental
    Perioperative yogatherapy plus standard surgery

    Participants undergo the indicated surgery for endometriosis and receive 32 live, guided yoga therapy sessions: 16 sessions during the 2 months before surgery and 16 sessions during the 3 months after surgery. Sessions are delivered by healthcare professionals trained in yoga therapy and combine adapted postures, breathing techniques, and meditative practices. A secure digital platform provides videos, audio materials, questionnaires, support for independent practice, and pseudonymised monitoring of session opening, initiation, interruption, completion, validation, frequency, and regularity.

    Procedure: Structured perioperative yogatherapy programme plus standard surgical management

  • Active comparator
    Standard surgery alone (control group)

    Standard surgical management for endometriosis

    Procedure: Standard surgical management for endometriosis

Interventions

  • ProcedureStandard surgical management for endometriosis

    Participants undergo the indicated surgery for endometriosis and receive standard perioperative and follow-up care, without study yoga therapy sessions. They complete the same scheduled clinical and patient-reported assessments as the intervention group.

  • ProcedureStructured perioperative yogatherapy programme plus standard surgical management

    Participants undergo the indicated surgery for endometriosis and receive 32 live, guided yoga therapy sessions: 16 sessions during the 2 months before surgery and 16 sessions during the 3 months after surgery. Sessions are delivered by healthcare professionals trained in yoga therapy and combine adapted postures, breathing techniques, and meditative practices. A secure digital platform provides videos, audio materials, questionnaires, support for independent practice, and pseudonymised monitoring of session opening, initiation, interruption, completion, validation, frequency, and regularity.

05

What researchers measure

Primary outcomes

  1. Change in endometriosis-related pain measured by the EHP-30 pain subscale

    Between-group difference in change from the preoperative baseline in the pain subscale of the Endometriosis Health Profile-30 (EHP-30), comparing perioperative yoga therapy plus standard surgery with standard surgery alone. The sample-size calculation is based on detecting an additional clinically relevant 11-point reduction in the EHP-30 pain subscore.

    Time frame: baseline3 Months6 monthes12 months after surgery

Secondary outcomes

  1. Endometriosis-specific and generic health-related quality of life

    Changes in the non-pain EHP-30 domains (control and powerlessness, emotional well-being, social support, and self-esteem) and in EQ-5D-5L dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). A subjective quality-of-life assessment is also recorded in the self-care book.

    Time frame: baseline3 months6 months12 months after surgery

  2. Pain characteristics, fatigue, sleep, emotional symptoms, sexual health, kinesiophobia, and daily functioning

    Pain intensity and sensory/affective characteristics are assessed using a 0-10 visual analogue scale and the short-form Saint-Antoine Pain Questionnaire. Anxiety and depressive symptoms are assessed with the Hospital Anxiety and Depression Scale. General health observations document sleep, fatigue, urinary and digestive symptoms, emotions, and bodily sensations. Sexual health, fear of movement, and limitations in activities of daily living are also evaluated.

    Time frame: baseline3 months6 months12 months after surgery. 14 days before each study visit

  3. Medication use, healthcare utilisation, hospitalisations, and work absenteeism

    Between-group comparison of medication use, healthcare contacts and consultations, hospital admissions, sick leave, and absence from work over the 12-month follow-up period.

    Time frame: baseline3 months6 months12 months after surgery. 14 days before each study visit

  4. Adherence, acceptability, satisfaction, and autonomous use of the digital platform

    Attendance at guided sessions, satisfaction with the programme, autonomy, and appropriation of the tools are evaluated. Pseudonymised platform metrics include opening, initiation, interruption, completion and validation of sessions, together with the frequency and regularity of independent practice.

    Time frame: During the 16 preoperative and 16 postoperative guided sessions3 to 9 months after surgery

06

Study locations

1 site
  • CHU de Lille
    Lille, 59000, France
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07765680
Lead sponsor
University Hospital, Lille
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Feb 1, 2028 (estimated)
Completion
Oct 1, 2029 (estimated)
Last update
Sep 21, 2026

Study contacts

RUBOD Chrystele Rubod Chrystele, PU-PH
Contact
chrystele.rubod@chu-lille.fr
03 20 43 11 24

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion